1,382
Views
25
CrossRef citations to date
0
Altmetric
Review

Obstructive sleep apnea: novel trigger and potential therapeutic target for cardiac arrhythmias

&
Pages 981-994 | Published online: 10 Jan 2014

References

  • Somers V, White D, Amin R et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. J. Am. Coll. Cardiol.52, 686–717 (2008).
  • Chami H, Devereux R, Gottdiener J et al. Left ventricular morphology and systolic function in sleep-disordered breathing. The Sleep Heart Health Study. Circulation117, 2599–2607 (2008).
  • Lattimore J, Celermajer D, Wilcox I. Sleep apnea and cardiovascular disease. J. Am. Coll. Cardiol.41, 1429–1437 (2003).
  • Seppälä T, Partinen M, Penttilä A, Aspholm R, Tiainen E, Kaukianen A. Sudden death and sleeping history among Finnish men. J. Int. Med.229, 23–28 (1991).
  • Valham F, Mooe T, Rabben T, Stenlund H, Wiklund U, Franklin K. Increased risk of stroke in patients with coronary artery disease and sleep apnea. A 10 year follow-up. Circulation118, 955–960 (2008).
  • Wilcox I, Semsarian C. Obstructive sleep apnea. A respiratory syndrome with protean cardiovascular manifestations. J. Am. Coll. Cardiol.54, 1810–1812 (2009).
  • Gami A, Howard D, Olson E, Somers V. Day–night pattern of sudden death in obstructive sleep apnea. N. Engl. J. Med.352, 1206–1214 (2005).
  • Dement W, Kleitman N. Cyclic variations in EEG during sleep and their relation to eye movements, body motility, and dreaming. Electroencephalogr. Clin. Neurophysiol.9, 673–690 (1957).
  • Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N. Engl. J. Med.328, 1230–1235 (1993).
  • Bixler E, Vgontzas A, Have TT, Tyson K, Kales A. Effects of age on sleep apnea in men: I. Prevalence and severity. Am. J. Respir. Crit. Care Med.157, 144–148 (1998).
  • Duran J, Esnaola S, Rubio R, Iztueta A. Obstructive sleep apneahypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am. J. Respir. Crit. Care Med.163, 685–689 (2001).
  • Young T, Evans L, Finn L, Palta M. Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women. Sleep20, 705–706 (1997).
  • Young T, Peppard P, Taheri S. Excess weight and sleep-disordered breathing. J. Appl. Physiol.99, 1592–1599 (2005).
  • Flemon W, Douglas N, Kuna S, Rodenstein D, Wheatley J. Access to diagnosis and treatment of patients with suspected sleep apnea. Am. J. Respir. Crit. Care Med.169, 668–672 (2004).
  • White D, Weil J, Zwillich C. Metabolic rate and breathing during sleep. J. Appl. Physiol.59, 384–391 (1985).
  • Mancia G. Autonomic modulation of the cardiovascular system during sleep. N. Engl. J. Med.328, 347–349 (1993).
  • Hornyak M, Cejnar M, Elam M, Matousek M, Wallin B. Sympathetic muscle nerve activity during sleep in man. Brain114, 1281–1295 (1991).
  • Somers V, Mark A, Zavala D, Abboud F. Contrasting effects of hypoxia and hypercapnia on ventilation and sympathetic activity in humans. J. Appl. Physiol.67, 2101–2106 (1989).
  • Stoohs R, Guilleminault C. Cardiovascular changes associated with obstructive sleep apnea syndrome. J. Appl. Physiol.72, 583–589 (1992).
  • Kusuoka H, Weisfeldt M, Zweier J, Jacobus W, Marban E. Mechanism of early contractile failure during hypoxia in intact ferret heart: evidence for modulation of maximal Ca2+-activated force by inorganic phosphate. Circ. Res.59, 270–282 (1986).
  • Daly M, Scott M. The cardiovascular responses to stimulation of the carotid chemoreceptors in the dog. J. Physiol.165, 179–197 (1963).
  • Daly M, Scott M. The effects of stimulation of the carotid body chemoreceptors on heart rate in the dog. J. Physiol.144, 148–166 (1958).
  • Leung R, Bradley T. Sleep apnea and cardiovascular disease. Am. J. Respir. Crit. Care Med.164, 2147–2165 (2001).
  • White S, Fletcher E, Miller C. Acute systemic blood pressure elevation in obstructive and nonobstructive breath hold in primates. J. Appl. Physiol.79, 324–330 (1995).
  • O’Donnell C, Ayuse T, King E, Schwartz A, Smith P, Robotham J. Airway obstruction during sleep increases blood pressure without arousal. J. Appl. Physiol.80, 773–781 (1996).
  • Chen L, Scharf S. Comparative hemodynamic effects of periodic obstructive and simulated central apneas in sedated pigs. J. Appl. Physiol.83, 485–494 (1997).
  • Brinker J, Weiss J, Lappe D et al. Leftward septal displacement during right ventricular loading in man. Circulation61, 626–633 (1980).
  • Bradley T. Right and left ventricular functional impairment and sleep apnea. Clin. Chest Med.13, 459–479 (1992).
  • Hall M, Ando S, Floras J, Bradley T. Magnitude and time course of hemodynamic responses to Mueller maneuvers in patients with congestive heart failure. J. Appl. Physiol.85, 1476–1484 (1998).
  • Guilleminault C, Motta J, Mihm F, Melvin K. Obstructive sleep apnea and cardiac index. Chest89, 331–334 (1986).
  • Tolle F, Judy W, Yu P, Markand O. Reduced stroke volume related to pleural pressure in obstructive sleep apnea. J. Appl. Physiol.55, 1718–1724 (1983).
  • Stoohs R, Guilleminault C. Cardiovascular changes associated with obstructive sleep apnea syndrome. J. Appl. Physiol.72, 583–589 (1992).
  • Oliveira W, Campos O, Lira-Filho EB et al. Left atrial volume and function in patients with obstructive sleep apnea assessed by real-time three-dimensional echocardiography. J. Am. Soc. Echocardiogr.21, 1355–1361 (2008).
  • Otto M, Belohlavek M, Romero-Corral A et al. Comparison of cardiac structural and functional changes in obese otherwise healthy adults with versus without obstructive sleep apnea. Am. J. Cardiol.99, 1298–1302 (2007).
  • Arias MA, García-Río F, Alonso-Fernández A, Mediano O, Martínez I, Villamor J. Obstructive sleep apnea syndrome affects left ventricular diastolic function: effects of nasal continuous positive airway pressure in men. Circulation112, 375–383 (2005).
  • Phillipson E, Bowes G. Control of breathing during sleep. In: Handbook of Physiology (Volume 2). Cherniack N, Widdicombe J (Eds). Williams & Wilkins, Bethesda, MD, USA, 649–689 (1986).
  • Horner R, Brooks D, Kozar L, Tse S, Phillipson E. Immediate effects of arousal from sleep on cardiac autonomic outflow in the absence of breathing in dogs. J. Appl. Physiol.79, 151–162 (1995).
  • Guyenet P. Lower brainstem mechanisms of respiratory integration. In: Sleep Apnea: Implications in Cardiovascular and Cerebrovascular Disease. Bradley T, Floras J (Eds). Marcel Dekker, NY, USA, 61–98 (2000).
  • Usui K, Parker J, Newton G, Floras J, Ryan C, Bradley T. Left ventricular structural adaptations to obstructive sleep apnea in dilated cardiomyopathy. Am. J. Respir. Crit. Care Med.173, 1170–1175 (2006).
  • Laaban J, Pascal-Sebaoun S, Bloch E, Orvoen-Frija E, Oppert J, Huchon G. Left ventricular systolic dysfunction in patients with obstructive sleep apnea syndrome. Chest122, 1133–1138 (2002).
  • Fung J, Li T, Choy D et al. Severe obstructive sleep apnea is associated with left ventricular diastolic dysfunction. Chest121, 422–429 (2002).
  • Romero-Corral A, Somers V, Pellikka P et al. Decreased right and left ventricular myocardial performance in obstructive sleep apnea. Chest132, 1863–1870 (2007).
  • Ip M, Tse H, Lam B, Tsang K, Lam W. Endothelial function in obstructive sleep apnea and response to treatment. Am. J. Respir. Crit. Care Med.169, 348–353 (2004).
  • Sanner B, Konermann M, Tepel M, Groetz J, Mummenhoff C, Zidek W. Platelet function in patients with obstructive sleep apnoea syndrome. Eur. Respir. J.16, 648–652 (2000).
  • Yokoe T, Minoguchi K, Matsuo H et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continous positive airway pressure. Circulation107, 1129–1134 (2003).
  • Somers V, Dyken M, Clary M, Abboud F. Sympathetic neural mechanisms in obstructive sleep apnea. J. Clin. Invest.96, 1897–1904 (1995).
  • Hedner J, Ejnell H, Sellgren J, Hedner T, Wallin G. Is high and fluctuating muscle nerve sympathetic activity in the sleep apnoea syndrome of pathogenetic importance for the development of hypertension? J. Hypertens. Suppl.6, S529–S531 (1988).
  • Carlson J, Hedner J, Elam M, Ejnell H, Sellgren J, Wallin B. Augmented resting sympathetic activity in awake patients with obstructive sleep apnea. Chest103, 1763–1768 (1993).
  • Narkiewicz K, Montano N, Cogliati C, van de Borne P, Dyken M, Somers V. Altered cardiovascular variability in obstructive sleep apnea. Circulation98, 1071–1077 (1998).
  • Narkiewicz K, van de Borne P, Cooley R, Dyken M, Somers V. Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation98, 772–776 (1998).
  • Carlson J, Rangemark C, Hedner J. Attenuated endothelium dependent vascular relaxation in patients with sleep apnoea. J. Hypertens.14, 577–584 (1996).
  • Kato M, Roberts-Thomson P, Phillips B et al. Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation102, 2607–2610 (2000).
  • Saarelainen S, Seppala E, Laasonen K, Hasan J. Circulating endothelin-1 in obstructive sleep apnea. Endothelium5, 115–118 (1997).
  • Grimpen F, Kanne P, Schulz E, Hagenah G, Hasenfuss G, Andreas S. Endothelin-1 plasma levels are not elevated in patients with obstructive sleep apnoea. Eur. Respir. J.15, 320–325 (2000).
  • Kraiczi H, Hedner J, Peker Y, Carlson J. Increased vasoconstrictor sensitivity in obstructive sleep apnea. J. Appl. Physiol.89, 493–498 (2000).
  • Parati G, Rienzo MD, Bonsignore M et al. Autonomic cardiac regulation in obstructive sleep apnea syndrome: evidence from spontaneous baroreflex analysis during sleep. J. Hypertens.15, 1621–1626 (1997).
  • Becker H, Jerrentrup A, Ploch T et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation107, 68–73 (2003).
  • Dean R, Wilcox I. Possible atherogenic effects of hypoxia during obstructive sleep apnea. Sleep16(Suppl. 8), S15–S21 (1993).
  • Drage L, Bortolotto L, Krieger E, Lorenzi-Filho G. Additive effects of obstructive sleep apnea and hypertension on early markers of atherosclerosis. Hypertension53, 64–69 (2009).
  • Sorajja D, Gami A, Somers V, Behrenbeck T, Garcia-Touchard A, Lopez-Jimenez F. Independent association between obstructive sleep apnea and subclinical coronary artery disease. Chest133, 927–933 (2008).
  • Peker Y, Carlson J, Hedner J. Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up. Eur. Respir. J.28, 596–602 (2006).
  • Lattimore J, Wilcox I, Skilton M, Langenfeld M, Celermajer D. Treatment of obstructive sleep apnoea leads to improved microvascular endothelial function in the systemic circulation. Thorax61, 491–495 (2006).
  • Jelic S, Lederer D, Adams T et al. Vascular inflammation in obesity and sleep apnea. Circulation121, 1014–1021 (2010).
  • Lattimore J, Wilcox I, Adams M, Kilian J, Celermajer D. Treatment of obstructive sleep apnoea leads to enhanced pulmonary vascular nitric oxide release. Int. J. Cardiol.126, 229–233 (2008).
  • Ryan S, Taylor C, McNicholas W. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation112, 2660–2667 (2005).
  • Ryan S, Taylor C, McNicholas W. Predictors of elevated nuclear factor-κB-dependent genes in obstructive sleep apnea syndrome. Am. J. Respir. Crit. Care Med.174, 824–830 (2006).
  • Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J. Respir. Crit. Care Med.165, 934–939 (2002).
  • Bedwell S, Dean R, Jessup W. The action of defined oxygen-centred free radicals on human low-density lipoprotein. Biochem. J.262, 707–712 (1989).
  • Faller D. Endothelial cell responses to hypoxic stress. Clin. Exp. Pharmacol. Physiol.26, 74–84 (1999).
  • El-Solh A, Mador M, Sikka P, Dhillon R, Amsterdam D, Grant B. Adhesion molecules in patients with coronary artery disease and moderate-to-severe obstructive sleep apnea. Chest121, 1541–1547 (2002).
  • Larsson P, Wallen N, Hjemdahl P. Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin. Circulation89, 1951–1957 (1994).
  • Bokinsky G, Miller M, Ault K, Husband P, Mitchell J. Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure. A preliminary investigation. Chest108, 625–630 (1995).
  • Dimsdale J, Coy T, Ziegler M, Ancoli-Israel S, Clausen J. The effect of sleep apnea on plasma and urinary catecholamines. Sleep18, 377–381 (1995).
  • Eisensehr I, Ehrenberg B, Noachtar S et al. Platelet activation, epinephrine, and blood pressure in obstructive sleep apnea syndrome. Neurology51, 188–195 (1998).
  • Hoffstein V, Herridge M, Mateika S, Redline S, Strohl K. Hematocrit levels in sleep apnea. Chest106, 787–791 (1994).
  • Chin K, Ohi M, Kita H et al. Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome. Am. J. Respir. Crit. Care Med.153, 1972–1976 (1996).
  • Nobili L, Schiavi G, Bozano E, Carli FD, Ferrillo F, Nobili F. Morning increase of whole blood viscosity in obstructive sleep apnea syndrome. Clin. Hemorheol. Microcirc.22, 21–27 (2000).
  • Lakka H, Lakka T, Tuomilehto J, Salonen J. Abdominal obesity is associated with increased risk of acute coronary events in men. Eur. Heart J.23, 706–713 (2002).
  • Hubert H, Feinleib M, McNamara P, Castelli W. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation67, 968–977 (1983).
  • Lee I, Manson J, Hennekens C, Paffenbarger R Jr. Body weight and mortality: a 27-year follow-up of middle-aged men. JAMA270, 2823–2828 (1993).
  • Rosito G, D’Agostino R, Massaro J et al. Association between obesity and a prothrombotic state: the Framingham Offspring Study. Thromb. Haemost.91, 683–689 (2004).
  • Ghanim H, Aljada A, Hofmeyer D, Syed T, Mohanty P, Dandona P. Circulating mononuclear cells in the obese are in a proinflammatory state. Circulation110, 1564–1571 (2004).
  • Ip M, Lam B, Ng M, Lam W, Tsang K, Lam K. Obstructive sleep apnea is independently associated with insulin resistance. Am. J. Respir. Crit. Care Med.165, 670–676 (2002).
  • Punjabi N, Sorkin J, Katzel L, Goldberg A, Schwartz A, Smith P. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am. J. Respir. Crit. Care Med.165, 677–682 (2002).
  • Wilcox I, McNamara S, Collins F, Grunstein R, Sullivan C. ‘Syndrome Z’: the interaction of sleep apnoea, vascular risk factors and heart disease. Thorax53(Suppl. 3), S25–S28 (1998).
  • Nock N, Li L, Larkin E, Patel S, Redline S. Empirical evidence for ‘Syndrome Z’: a hierarchical 5-factor model of the metabolic syndrome incorporating sleep disturbance measures. Sleep32, 615–622 (2009).
  • Coumel P. Cardiac arrhythmias and the autonomic nervous system. J. Cardiovasc. Physiol.4, 338–355 (1993).
  • Peled N, Abinader E, Pillar G, Sharif D, Lavie P. Nocturnal ischemic events in patients with obstructive sleep apnea syndrome and ischemic heart disease J. Am. Coll. Cardiol.34, 1744–1749 (1999).
  • Krieger J, Laks L, Wilcox I et al. Atrial natriuretic peptide release during sleep in patients with obstructive sleep apnoea before and during treatment with nasal continuous positive airway pressure. Clin. Sci.77, 407–411 (1989).
  • Flemons W, Remmers J, Gillis A. Sleep apnea and cardiac arrhythmias. Is there a relationship? Am. Rev. Respir. Dis.148, 618–621 (1993).
  • Mehra R, Benjamin E, Shahar E et al. Association of nocturnal arrhythmias with sleep-disordered breathing. The Sleep Heart Health Study. Am. J. Respir. Crit. Care Med.173, 910–916 (2006).
  • Becker H, Koehler U, Stammnitz A, Peter J. Heart block in patients with sleep apnoea. Thorax53, 29–32 (1998).
  • Guilleminault C, Connolly S, Winkle R. Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J. Cardiol.52, 490–494 (1983).
  • Tilkian A, Guilleminault C, Schroeder J, Lehrman K, Simmons F, Dement W. Sleep-induced apnea syndrome. Prevalence of cardiac arrhythmias and their reversal after tracheostomy. Am. J. Med.63, 348–358 (1977).
  • Simantirakis E, Schiza S, Marketou M et al. Severe bradyarrhythmias in patients with sleep apnoea: the effect of continuous positive airway pressure treatment: a long-term evaluation using an insertable loop recorder. Eur. Heart J.25, 1070–1076 (2004).
  • Harbison J, O’Reilly P, McNicholas W. Cardiac rhythm disturbances in the obstructive sleep apnea syndrome: effects of nasal continuous positive airway pressure therapy. Chest118, 591–595 (2000).
  • Grimm W, Koehler U, Fus E et al. Outcome of patients with sleep apnea-associated severe bradyarrhythmias after continuous positive airway pressure therapy. Am. J. Cardiol.86, 688–692, A9 (2000).
  • Koehler U, Fus E, Grimm W et al. Heart block in patients with obstructive sleep apnoea: pathogenetic factors and effects of treatment. Eur. Respir. J.11, 434–439 (1998).
  • Stegman S, Burroughs J, Henthorn R. Asymptomatic bradyarrhythmias as a marker for sleep apnea: appropriate recognition and treatment may reduce the need for pacemaker therapy. Pacing Clin. Electrophysiol.19, 899–904 (1996).
  • Grimm W, Hoffmann J, Menz V et al. Electrophysiologic evaluation of sinus node function and atrioventricular conduction in patients with prolonged ventricular asystole during obstructive sleep apnea. Am. J. Cardiol.77, 1310–1314 (1996).
  • Zwillich C, Devlin T, White D, Douglas N, Weill J, Martin R. Bradycardia during sleep apnea: characteristics and mechanism. J. Clin. Invest.69, 1286–1292 (1982).
  • Garrigue S, Pepin J, Defaye P et al. High prevalence of sleep apnea syndrome in patients with long-term pacing. The European multicenter polysomnographic study. Circulation115, 1703–1709 (2007).
  • Garrigue S, Bordier P, Jaïs P et al. Benefit of atrial pacing in sleep apnea syndrome. N. Engl. J. Med.346, 404–412 (2002).
  • Pepin J, Defaye P, Garrigue S, Poezevara Y, Levy P. Overdrive atrial pacing does not improve obstructive sleep apnoea syndrome. Eur. Respir. J.25, 343–347 (2005).
  • Sharafkhaneh A, Sharafkhaneh H, Bredikus A, Guilleminault C, Bozkurt B, Hirshkowitz M. Effect of atrial overdrive pacing on obstructive sleep apnea in patients with systolic heart failure. Sleep Med.8, 31–36 (2007).
  • Weng C, Chen Q, Ma Y, He Q. A meta-analysis of the effects of atrial overdrive pacing on sleep apnea syndrome. Pacing Clin. Electrophysiol.32, 1434–1443 (2009).
  • Gami A, Pressman G, Caples S et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation110, 364–367 (2004).
  • Stevenson I, Teichtahl H, Cunnington D, Ciavarella S, Gordon I, Kalman J. Prevalence of sleep disordered breathing in paroxysmal and persistent atrial fibrillation patients with normal left ventricular function. Eur. Heart J.29, 1662–1669 (2008).
  • Kanagala R, Murali N, Friedman P et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation107, 2589–2594 (2003).
  • Gami A, Hodge D, Herges R et al. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J. Am. Coll. Cardiol.49, 565–571 (2007).
  • Wyse D, Waldo A, DiMarco J et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N. Engl. J. Med.347, 1825–1833 (2002).
  • Hagens V, Ranchor A, Sonderen EV et al. Effect of rate or rhythm control on quality of life in persistent atrial fibrillation: results from the Rate Control Versus Electrical Cardioversion (RACE) Study. J. Am. Coll. Cardiol.43, 241–247 (2004).
  • Carlsson J, Miketic S, Windeler J et al. Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study. J. Am. Coll. Cardiol.41, 1690–1696 (2003).
  • Mooe T, Gullsby S, Rabben T, Eriksson P. Sleep-disordered breathing: a novel predictor of atrial fibrillation after coronary artery bypass surgery. Coron. Artery Dis.7, 475–478 (1996).
  • Monahan K, Storfer-Isser A, Mehra R et al. Triggering of nocturnal arrhythmias by sleep-disordered breathing events. J. Am. Coll. Cardiol.54, 1797–1804 (2009).
  • Schulz R, Eisele H, Seeger W. Nocturnal atrial fibrillation in a patient with obstructive sleep apnoea. Thorax60, 174 (2005).
  • Edwards N, Blyton D, Kirjavainen T, Kesby G, Sullivan C. Nasal continuous positive airway pressure reduces sleep-induced blood pressure increments in preeclampsia. Am. J. Respir. Crit. Care Med.162, 252–257 (2000).
  • Yaggi H, Concato J, Kernan W, Lichtman J, Brass L, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N. Engl. J. Med.353, 2034–2041 (2005).
  • Redline S, Yenokyan G, Gottlieb D et al. Obstructive sleep apnea hypopnea and incident stroke: the Sleep Heart Health Study. Am. J. Respir. Crit. Care Med. DOI: 10.1164/rccm.200911–1746OC (2010) (Epub ahead of print).
  • Hays A, Sacco R, Rundek T et al. Left ventricular systolic dysfunction and the risk of ischemic stroke in a multiethnic population. Stroke37, 1715–1719 (2006).
  • Eleid M, Konecny T, Orban M et al. High prevalence of abnormal nocturnal oximetry in patients with hypertrophic cardiomyopathy. J. Am. Coll. Cardiol.54, 1805–1809 (2009).
  • Sullivan C, Issa F, Berthon-Jones M, Eves L. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet1(8225), 862–865 (1981).
  • Abe H, Takahashi M, Yaegashi H et al. Efficacy of continuous positive airway pressure on arrhythmias in obstructive sleep apnea patients. Heart Vessels25, 63–69 (2010).
  • Cohen M, Rohtla K, Lavery C, Muller J, Mittleman M. Meta-analysis of the morning excess of acute myocardial infarction and sudden cardiac death. Am. J. Cardiol.79, 1512–1516 (1997).
  • Franklin K, Nisson J, Sahlin C, Naslund U. Sleep apnea and nocturnal angina. Lancet345, 1085–1087 (1995).
  • Schafer H, Koehler U, Ploch T, Peter J. Sleep related myocardial ischemia and sleep structure in patients with obstructive sleep apnea and coronary heart disease. Chest111, 387–393 (1997).
  • Hanly P, Sasson Z, Zuberi N, Lunn K. ST segment depression during sleep in obstructive sleep apnea. Am. J. Cardiol.71, 1341–1345 (1993).
  • Alonso-Fernández A, García-Río F, Racionero M et al. Cardiac rhythm disturbances and ST-segment depression episodes in patients with obstructive apnea-hypopnea syndrome and its mechanisms. Chest127, 15–22 (2005).
  • Peled N, Abinader E, Pillar G, Sharif D, Lavie P. Nocturnal ischemic events in patients with obstructive sleep apnea syndrome and ischemic heart disease. Effects of continuous positive air pressure treatment. J. Am. Coll. Cardiol.34, 1744–1749 (1999).
  • Ryan C, Usui K, Floras J, Bradley T. Effect of continuous positive airway pressure on ventricular ectopy in heart failure patients with obstructive sleep apnoea. Thorax60, 781–785 (2005).
  • Craig S, Pepperell J, Kohler M, Crosthwaite N, Davies R, Stradling J. Continuous positive airway pressure treatment for obstructive sleep apnoea reduces resting heart rate but does not affect dysrhythmias: a randomised controlled trial. J. Sleep Res.18, 329–336 (2009).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.